Navigation Links
Cell Therapeutics Announces Receipt of NASDAQ Listing Update
Date:3/6/2009

SEATTLE, March 6 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the Company received a letter from The NASDAQ Stock Market indicating that the NASDAQ Listing Qualifications Panel has determined to continue the listing of the Company's common stock on The NASDAQ Capital Market, subject to the condition that, on or before April 6, 2009, the Company demonstrate compliance with all applicable standards for continued listing on The NASDAQ Capital Market, including the $35 million market value of listed securities requirement or one of its alternatives.

As disclosed on September 6, 2008 and October 10, 2008, the Company was previously notified by NASDAQ regarding its non-compliance with the $50 million market value of listed securities requirement for continued listing on The NASDAQ Global Market. At the Company's request, on January 6, 2009, the Panel determined to transfer the listing of the Company's common stock from The NASDAQ Global Market to The NASDAQ Capital Market, subject to the Company demonstrating compliance with the applicable requirements for continued listing on The NASDAQ Capital Market by February 12, 2009, which period has since been extended through April 6, 2009.

The letter also included a public reprimand in connection with the Company's non-compliance with the shareholder approval and listing of additional shares requirements set forth in Marketplace Rules 4350(i) and 4310(c)(17), respectively, as previously disclosed by the Company in a press release dated January 26, 2009 and Current Report on Form 8-K as filed on January 29, 2009. Those deficiencies have already been remedied.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit '/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Proteon Therapeutics Completes $38M Equity Financing; Initiates Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients and Signs Option Agreement With Major Pharmaceutical Company
2. Pharmexa and Affitech to Combine Operations to Create a New Antibody Therapeutics Company
3. ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results
4. Pearl Therapeutics Appoints Perry Karsen as Chief Executive Officer
5. CV Therapeutics Advises Stockholders to Take No Action at This Time in Response to Astellas Tender Offer
6. Cornerstone Therapeutics to Host Quarter and Year Ended December 31, 2008 Conference Call
7. BN ImmunoTherapeutics Reports Further Data on PROSTVAC(TM)
8. Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results
9. Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE Alternext and Terminate SEC Registration of Common Stock
10. Pearl Therapeutics Secures $8 Million in Debt Financing
11. Amsterdam Molecular Therapeutics Reports Full Year Results 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 2015 Results from a Phase III ... its ability to reduce the size of melanoma tumors ... in the Journal of Clinical Oncology. , The ... IIIC and IV melanoma, a potentially fatal form of ... to evaluate the safety and efficacy of the oncolytic ...
(Date:5/28/2015)... May 28, 2015 ... announced the addition of Jain PharmaBiotech,s new ... Markets, and Companies" to their offering. ... This report deals with therapeutic drug ... improving patient care by monitoring drug levels ...
(Date:5/28/2015)... Research and Markets( http://www.researchandmarkets.com/research/l9dqwt/animal_genetics ) has announced ... Products, by Testing services - Global Forecast to 2020" ... animal genetics market is estimated to be worth around ... of 8-9% during the forecast period of 2014 to ... increasing animal protein consumption, increasing adoption of advanced genetic ...
(Date:5/28/2015)... N.J. , May 28, 2015 Celsion ... that it has received commitments from two institutional healthcare ... of the Company,s common stock in an at-the-market registered ... to purchase common stock. The Company entered ... to which the Company agreed to sell an aggregate ...
Breaking Biology Technology:Study Published in Journal of Clinical Oncology Reports Talimogene Laherparepvec Improvesdurable Responses in Patients with Advanced Melanoma 2Global Therapeutic Drug Monitoring Market 2015-2024 2Global Animal Genetics (Canine, Equine, Poultry, Porcine, Bovine, and Genetic Material) Market 2015 - Global Forecast to 2020 2Celsion Corporation Announces $8 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $8 Million At-The-Market Registered Direct Offering 3
... DALLAS, January 9, 2012 ReportsnReports adds ... on Global and   China   Hemodialysis Machine Industry ... and in-depth research report on Global and China Hemodialysis ... background knowledge of Hemodialysis Machine (single pump double pumo ...
... today that it has secured $47.5 million in Series ... financing along with existing investors OrbiMed Advisors, New Enterprise ... financing, Josh Bilenker, M.D., Partner at Aisling Capital, will ... round will support commercialization of the company,s Atlas™ System ...
... PHOENIX, Jan. 6, 2012  VisionGate, Inc., a company developing ... lung cancer and other applications, today reported that it ... proprietary imaging platform that generates high-resolution 3D biosignatures from ... funded in part by a $2.6 million ...
Cached Biology Technology:Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports 2Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports 3Roka Bioscience Secures $47.5 Million in Series D Financing 2VisionGate Uses $2.6 Million NIH Grant to Achieve Full Automation of Cell-CT™ 3D Imaging System for Early Diagnosis of Cancer 2VisionGate Uses $2.6 Million NIH Grant to Achieve Full Automation of Cell-CT™ 3D Imaging System for Early Diagnosis of Cancer 3VisionGate Uses $2.6 Million NIH Grant to Achieve Full Automation of Cell-CT™ 3D Imaging System for Early Diagnosis of Cancer 4
(Date:4/27/2015)... -- For more than four decades, AUVSI,s Unmanned Systems ... worldwide event for the unmanned land, sea, and air ... any local, national, or trade news organization interested in ... current applications of unmanned technologies. The conference will explore ... industry, and how it will soon impact the lives ...
(Date:4/21/2015)... -- High crime rate, increasing government ... control systems market in Saudi Arabia ... report by TechSci Research " Saudi Arabia Access Control Systems Market ... market in Saudi Arabia is ... systems market in the Kingdom is growing at a ...
(Date:4/17/2015)... BURNABY, Canada , April 17, 2015 /PRNewswire/ ... projects, growing security concerns, and technological advancement to ... Arabia until 2020   ... " Saudi Arabia Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric ... is projected to register growth at CAGR ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3
... (July 4, 2011) Autism Speaks, the world,s largest ... findings from the largest known study of twins with ... consortium of renowned researchers and using material from Autism ... today in the Archives of General Psychiatry . ...
... July 4, 2011 For several years, scientists have been ... disease type 2D: how can different types of mutations, spread ... a team of scientists at The Scripps Research Institute may ... which is mutated in individuals with the disease, the team ...
... which could provide an alternative to the toxic paints currently ... by German scientists. Scientists from the Biomimetics-Innovation-Centre have developed a ... of palm tree. "These plants have seeds which are dispersed ... these seeds to remain free of fouling to allow them ...
Cached Biology News:Study finds pregnancy and birth environment may affect development of autism in twins 2Scripps Research scientists solve mystery of nerve disease genes 2Scripps Research scientists solve mystery of nerve disease genes 3Scripps Research scientists solve mystery of nerve disease genes 4Specialized seeds can really float your boat 2